Roche, Regeneron link up to develop COVID-19 antibody cocktail
Go back to Roche, Regeneron link up to develop COVID-19 antibody cocktail| Regeneron (NASDAQ: REGN) | Delayed: 793.26 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $793.26 | 52 Week High | $592.36 | |||
| Open | $793.26 | 52 Week Low | $325.35 | |||
| Day High | $793.26 | P/E | 208.20 | |||
| Day Low | $793.26 | EPS | $3.81 | |||
| Volume | 14 | |||||
| ROGERS CORPORATION (NYSE: ROG) | Delayed: 132.68 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $132.68 | 52 Week High | $76.55 | |||
| Open | $132.68 | 52 Week Low | $41.92 | |||
| Day High | $132.68 | P/E | 74.96 | |||
| Day Low | $132.68 | EPS | $1.77 | |||
| Volume | 324 | |||||
